M. Peter Marinkovich
Academic Appointments
- Associate Professor, Dermatology
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Medical Dermatology 450 Broadway ST Pav B FL 4 MC 5338 Redwood City, CA 94063 Tel Work (650) 723-6316 Fax (650) 721-7796
- Academic Offices
Personal Information Email Tel (650) 498-5425Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Cutaneous (Dermatologic) Oncology
- Dermatology
- Autoimmune Blistering Diseases
- Epidermolysis Bullosa
Administrative Appointments
- Member, Institute for Immunity, Transplantation and Infection (ITI) (2011 - present)
- Founding Member/Core Investigator, Program in Epithelial Biology, Stanford University (1999 - present)
- Director, Blistering Disease Clinic, Department of Dermatology, Stanford University School of Medicine (1995 - present)
- Attending Physician, Dermatology Service, Palo Alto VA Medical Center (1995 - present)
- Member, Medical Institutional Review Board 4, Stanford University School of Medicine (2005 - present)
- Member, Cancer Center, Stanford University School of Medicine (2004 - present)
Professional Education
| Residency: | Oregon Health Science University OR (1994) |
| Board Certification: | Dermatology, American Board of Dermatology (1995) |
| Fellowship: | Shriner's Hospital - Portland OR (1990) |
| Internship: | *UCSF House Staff Office CA (1989) |
| Medical Education: | St. Louis University School of Medicine MO (1988) |
Postdoctoral Advisees
Ricardo De Azevedo Pereira, Nazanin Ehsani-Chimeh, Javier Fernandez-Alcudia, Carl Gustaf Winge, Zhenjie Xu
Graduate & Fellowship Program Affiliations
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
The extracellular matrix of epithelial tissues plays a critical role in many important biological processes such as tissue development and differentiation, wound healing, tumor invasion, cell proliferation and cell migration. A highly organized array of these molecules, termed the basement membrane, lies at the interface of epithelial tissues with surrounding stroma. Cell surface receptors termed integrins transmit the informational cues brought about by changes in the extracellular environment, and transmit them, via intracellular signaling, to effect changes in epithelial gene expression. Laminins and collagens are molecules of the extracellular matrix which play particularly crucial roles in epithelial development.
EXTRACELLULAR MATRIX IN CARCINOMA INVASION
Laminin-5 and its cell surface receptor a6b4 integrin are required for development of squamous cell carcinomas. Lack of either of these molecules results in a lack of tumor growth, whereas overexpression of these molecules correlates with increasing tumor invasiveness and a worsening patient prognosis. We have identified that laminin-5 undergoes proteolytic processing of two of its three chains, via mammalian Tolloid, a metalloprotease of the astacin family. Processing of laminin-5 promotes tumor invasion. We are currently studying the mechanisms whereby these processing events influence tumor cell invasion, migration and metastasis. Type VII collagen appears to play a key role in tumor invasion, and appears to operate through association with laminin-5. We are currently studying the mechanism of this association and its role in tumorigenesis. The laminin-5 receptor a6b4 integrin interacts with laminin-5 at one end and with intracellular protein complexes at the other end, through which it transmits important signaling information to the cell. Disruption of laminin-5 binding or binding to the intracellular protein plectin, through site directed mutagenesis results in a lack of tumor growth, indicating that integrin binding to laminin-5 and integrin binding to plectin are both critical in tumor progression. We are currently studying the mechanisms whereby these binding events promote tumor progression. The molecule collagen XVII is closely associated with laminin-5 and a6b4 integrin and also is required for tumor invasion. The C-terminal extracellular domain of this molecule appears to play a critical role in interaction with extracellular matrix molecules and in organizing cell adhesion structures. It is also a focus of our studies of the role of extracellular matrix in tumor progression.
EXTRACELLULAR MATRIX IN HAIR DEVELOPMENT
Laminin-10 is a widely expressed molecule found in a number of epithelial tissues. Lack of laminin-10 in lama5 -/- mice results in aberrant tissue development. In the skin, there is a complete lack of hair follicle development. Exogenous delivery of laminin-10 rescues hair development in lama5 -/- skin. Laminin-10 appears to act as a potent morphogen, stimulating hair follicle development in the skin of these mice. We are currently examining this system to further understand the mechanisms whereby laminin-10 facilitates hair follicle development and basal cell carcinoma invasion, a developmentally similar process.
EXTRACELLULAR MATRIX IN EPITHELIAL ADHESION
Laminin-5, a6b4 integrin, type VII collagen and type XVII collagen each promote epithelial-mesenchymal cohesion. Defects of these molecule, in the inherited group of diseases known as epidermolysis bullosa, result in profound epithelial adhesion defects, causing extensive skin and mucosal blisters and erosions. As part of a Departmental effort, in association with the Khavari laboratory, our laboratory is participating in the study of new and novel forms of extracellular matrix gene replacement in these adhesion disorders, with the goal of translating these techniques to the clinical setting.
Clinical Trials
- Recruiting Characteristics of Patients With Dystrophic Epidermolysis Bullosa
- Recruiting Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
- Recruiting Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes
- Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Publications
- Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. Genes Dev. 2008; (15): 2111-24
- Targeting a tumor-specific laminin domain critical for human carcinogenesis. Cancer Res. 2008; (8): 2885-94
- A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res. 2007; (9): 4264-70
- Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer. 2007; (5): 370-80
- Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science. 2005; (5716): 1773-6
- Linear immunoglobulin A bullous dermatosis. Clin Dermatol. 2012 Jan-Feb; (1): 38-50

